Suppr超能文献

2010 - 2013年至2022年加拿大城市污水和生物固体中的药品及个人护理产品:存在情况、去向及时间趋势

Pharmaceuticals and personal care products in Canadian municipal wastewater and biosolids: occurrence, fate, and time trends 2010-2013 to 2022.

作者信息

Gewurtz Sarah B, Auyeung Alexandra S, Teslic Steven, Smyth Shirley Anne

机构信息

Science and Technology Branch, Environment and Climate Change Canada, Burlington, ON, L7S 1A1, Canada.

出版信息

Environ Sci Pollut Res Int. 2025 Feb;32(9):5022-5039. doi: 10.1007/s11356-025-36007-0. Epub 2025 Feb 3.

Abstract

The concentrations of 135 pharmaceuticals and personal care products (PPCPs) were determined in raw influent, final effluent, and treated biosolids at Canadian wastewater treatment plants (WWTPs) to evaluate the fate of PPCPs through liquid and solids trains of typical treatment types used in Canada and to assess changes in PPCP concentrations in wastewater matrices between 2010-2013 and 2022. PPCPs dominant in influent and effluent included the antidiabetic metformin, analgesics/anti-inflammatories (acetaminophen, ibuprofen, 2-hydroxy-ibuprofen), caffeine and its metabolite (1,7 - dimethylxanthine), theophylline (a bronchodilator and metabolite of caffeine), an insect repellent (N,N-diethyl-m-toluamide, DEET), and iopamidol (a contrast media for X-rays). PPCPs dominant in biosolids differed from those in influent/effluent and included antibiotics (fluoroquinolones and doxycycline), antidepressants (sertraline, citalopram, and amitriptyline), a preservative and antimicrobial agent (triclosan), an antihistamine (diphenhydramine), and an antifungal (clotrimazole). These elevated concentrations in influent/effluent and biosolids reflected their use in Canadian communities. PPCPs dominant in influent/effluent had relatively low hydrophobicity whereas those in biosolids tended to be more hydrophobic, or electrostatic forces governed their sorption. Higher removal of PPCPs was generally observed at WWTPs that used biological treatment compared to primary physical/chemical treatment. PPCP concentration changes in wastewater matrices between 2010-2013 and 2022 were influenced by risk management measures, warnings, the development of new pharmaceuticals, the COVID-19 pandemic, and other factors. These time trends reflected the limited information available on PPCP use in Canada. Continued periodic monitoring of PPCPs is recommended to fill data gaps on community use and release to the environment.

摘要

对加拿大污水处理厂(WWTPs)的原进水、最终出水和处理后的生物固体中的135种药品和个人护理产品(PPCPs)浓度进行了测定,以评估PPCPs在加拿大使用的典型处理类型的液体和固体流程中的去向,并评估2010 - 2013年至2022年期间废水基质中PPCPs浓度的变化。进水和出水中占主导地位的PPCPs包括抗糖尿病药物二甲双胍、止痛/抗炎药(对乙酰氨基酚、布洛芬、2 - 羟基布洛芬)、咖啡因及其代谢物(1,7 - 二甲基黄嘌呤)、茶碱(一种支气管扩张剂和咖啡因的代谢物)、一种驱虫剂(N,N - 二乙基 - m - 甲苯胺,避蚊胺)和碘帕醇(一种X射线造影剂)。生物固体中占主导地位的PPCPs与进水/出水中的不同,包括抗生素(氟喹诺酮类和多西环素)、抗抑郁药(舍曲林、西酞普兰和阿米替林)、一种防腐剂和抗菌剂(三氯生)、一种抗组胺药(苯海拉明)和一种抗真菌药(克霉唑)。进水/出水和生物固体中的这些升高浓度反映了它们在加拿大社区的使用情况。进水/出水中占主导地位的PPCPs疏水性相对较低,而生物固体中的那些往往疏水性更强,或者静电作用力控制着它们的吸附。与初级物理/化学处理相比,在使用生物处理的污水处理厂中,通常观察到PPCPs的去除率更高。2010 - 2013年至2022年期间废水基质中PPCP浓度的变化受到风险管理措施、警告、新药品的开发、COVID - 19大流行和其他因素的影响。这些时间趋势反映了加拿大关于PPCP使用的可用信息有限。建议持续定期监测PPCPs,以填补关于社区使用和向环境释放的数据空白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10dd/11868229/b19dd81ba1ce/11356_2025_36007_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验